September’s top ophthalmology-related news included FDA advancements for multiple drugs and a notable recall of bevacizumab.
Here are the top five articles on Healio.com/OSN in September:
AmEx recalls all lots of bevacizumab
All lots of bevacizumab 1.25 mg/0.05 mL 31-gauge injectable and bevacizumab 2.5 mg/0.1 mL Normject TB injectable from Pacifico National, doing business as AmEx Pharmacy, have been voluntarily recalled by the company. Read more.
VIDEO: J&J Vision launches Tecnis Synergy IOL, preloaded injectors
At the European Society of Cataract and Refractive Surgeons
Uncategorized